Last updated on April 2018

Topical Omega-3 Fatty Acids (REMOGEN OMEGA) in the Treatment of Dry Eye


Brief description of study

The primary objective of this study is to evaluate the efficacy of REMOGEN OMEGA in reducing Dry Eye Syndrome (DES) symptoms.

Clinical Study Identifier: NCT02908282

Contact Investigators or Research Sites near you

Start Over

Raphaela Geiger

Praxis Dr. Kaercher
Heidelberg, Germany

Elisabeth Messmer, Prof. Dr.

Praxis Prof. Dr. Anselm Kampik & Kollegen
Munich, Germany

Thomas Berninger, Prof. Dr.

Augenzentrum Olching
Olching, Germany

Christina Jacobi, PD Dr. med.

Dr. Flamm & B ker: Augen rzte am Tibarg
Hamburg, Germany

Klaudia Huber-van der Velden, PD ...

Augenheilkunde Lindenthal
Köln-Lindenthal, Germany